Explore
Trendline
Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule
Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule
Read More
Trendline
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Read More
Trendline
Opening Bell: U.S. Stock Markets Begin Trading on May 18, 2026
Opening Bell: U.S. Stock Markets Begin Trading on May 18, 2026
Read More
Trendline
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Read More
Trendline
SpaceX Accelerates IPO Plans, Aiming for Nasdaq Listing by June
SpaceX Accelerates IPO Plans, Aiming for Nasdaq Listing by June
Read More
Trendline
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations
Read More
AP News
Oil prices keep swinging up and down, and so do stocks worldwide
Oil prices swung after a scare overnight where prices popped and then moderated, and the yo-yo moves kept stock markets worldwide unsettled
Read More
Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Read More
Reuters
Trading Day: Yields squeeze stocks
By Jamie McGeever ORLANDO, Florida, May 18 (Reuters) - Stocks mostly retreated on Monday as a deepening global bond rout drove yields to historic highs, darkening the economic outlook and casting a shadow over the AI rally ahead of Nvidia's quarterly earnings report later in the week.
Read More
Trendline
Silexion Therapeutics Reports Increased Net Loss Amid Clinical Preparations
Silexion Therapeutics Reports Increased Net Loss Amid Clinical Preparations
Read More
Trendline
Silexion Therapeutics Reports Increased Net Loss Amid R Expansion for SIL204
Silexion Therapeutics Reports Increased Net Loss Amid R Expansion for SIL204
Read More
Trendline
Cathie Wood's ARK Invest Acquires Shares in Cerebras Following AI IPO Surge
Cathie Wood's ARK Invest Acquires Shares in Cerebras Following AI IPO Surge
Read More